Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Relapsed and/or Refractory Multiple Myeloma
Beijing
Relapsed and/or Refractory Multiple Myeloma Clinical Trials in Beijing
1 recruiting
Beijing, China
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
Relapsed and/or Refractory Multiple Myeloma
OriCell Therapeutics Co., Ltd.
83 enrolled
5 locations
NCT06182696
Feedback